Cancer vaccine approved by FDA for human testing

Breast Cancer News / Breast Cancer Research / September 19, 2011

Like this? Try this
New therapy a possible alternative for women resistant to Herceptin
A newly-developed protein called Affitoxin has been shown in lab tests to effectively destroy HER2-positive breast tumors...

View More In This Category